21 February 2019 (Thursday) - Apixiban
Here’s an interesting article about the use of apixaban to prevent venous thromboembolism in patients with various cancers. It came to be via the Facebook BMT and Hematological Malignancy Interest Group which up to now hasn’t been that active.
Is it perking up? Let’s hope so…
Labels: journal review